Sanjay Govil, the US-based tech entrepreneur and owner of Washington Freedom, is set to buy a minority stake in Welsh Fire, ...
– Proceeds will support two double-blind Phase 2 clinical trials of lead candidate, XC001, which has demonstrated transformative potential for treatment of refractory angina KING OF PRUSSIA, Pa ...